CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-13 | Durso Jerome Benedict President and CEO | Purchase | +15,000 | $2.95 | $44K | 62,500 |
| 2026-04-06 | GILL JOHN Director | Purchase | +9,200 | $3.41 | $31K | 21,700 |
| 2026-04-01 | Durso Jerome Benedict President and CEO | Purchase | +15,000 | $3.14 | $47K | 47,500 |
| 2026-04-01 | WEAVER GREGORY L Chief Financial Officer | Purchase | +10,000 | $3.15 | $31K | 38,078 |
| 2026-03-06 | Durso Jerome Benedict President and CEO | Purchase | +20,000 | $3.54 | $71K | 32,500 |
| 2026-03-06 | WEAVER GREGORY L Chief Financial Officer | Purchase | +5,000 | $3.54 | $18K | 28,078 |
| 2026-01-08 | Pisano Wayne Director | Purchase | +5,000 | $4.08 | $20K | 13,498 |
| 2026-01-05 | Sohn Catherine A. Director | Purchase | +500 | $4.24 | $2K | 1,500 |
| 2025-12-29 | Jorkasky Diane Director | Purchase | +527 | $3.80 | $2K | 527 |
| 2025-12-23 | GILL JOHN Director | Purchase | +12,500 | $4.10 | $51K | 12,500 |
| 2025-12-22 | Durso Jerome Benedict Director | Purchase | +12,500 | $4.13 | $52K | 12,500 |
| 2025-03-17 | Sohn Catherine A. Director | Purchase | +1,000 | $5.78 | $6K | 1,000 |
| 2025-03-13 | WEAVER GREGORY L Chief Financial Officer | Purchase | +10,000 | $5.20 | $52K | 10,000 |
| 2023-08-15 | Drutz David Director | Purchase | +300 | $2.88 | $863 | 29,785 |
| 2023-03-24 | Eisenstadt Richard I Chief Financial Officer | Purchase | +10,000 | $4.31 | $43K | 22,010 |
| 2023-03-23 | Drutz David Director | Purchase | +9,000 | $4.27 | $38K | 29,484 |
| 2023-03-23 | Harris Matthew Scott Chief Medical Officer | Purchase | +10,000 | $4.22 | $42K | 33,311 |
| 2022-06-15 | Drutz David Director | Purchase | +1,000 | $8.00 | $8K | 20,012 |
| 2022-05-24 | Drutz David Director | Purchase | +1,200 | $4.50 | $5K | 19,012 |
Page 1 of 1 · 19 trades